Compare PCYO & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCYO | ACB |
|---|---|---|
| Founded | 1976 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Water Supply | Pharmaceuticals and Biotechnology |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 264.1M | 232.3M |
| IPO Year | 1995 | 2016 |
| Metric | PCYO | ACB |
|---|---|---|
| Price | $10.61 | $4.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 66.2K | ★ 1.0M |
| Earning Date | 11-11-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.50 | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $1,227,787.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.38 |
| P/E Ratio | $29.03 | ★ N/A |
| Revenue Growth | ★ 171.54 | N/A |
| 52 Week Low | $9.71 | $2.56 |
| 52 Week High | $12.44 | $6.36 |
| Indicator | PCYO | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 41.63 | 48.85 |
| Support Level | $10.53 | $3.75 |
| Resistance Level | $10.72 | $4.20 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 23.60 | 25.17 |
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.